Boston Scientific receives FDA clearance for next generation SpyGlass direct visualization system

Boston Scientific received FDA 510(k) clearance for its SpyGlass DS Direct Visualization System.

Advertisement

The system is cleared for use in the diagnosis and treatment of pancreatico-biliary disease. The first cases involving use of the system were cholangioscopy and pancreatoscopy procedures. The system is built on the technology of the original SpyGlass System, and aims to optimize procedural efficiency and productivity.

More articles on GI/endoscopy:

GI physician leader to know: Dr. Anthony DiMarino of Jefferson University Hospitals
Boston Scientific SVP sold 11k+ shares: 4 things to know
APIC, SHEA address infections linked to duodenscopes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.